Adlai Nortye (ANL) Enterprise Value (2022 - 2025)
Adlai Nortye (ANL) reported Enterprise Value of -$8.1 million for Q4 2025, up 86.77% year-over-year from -$4.3 million in Q4 2024, and up 86.77% on a QoQ basis from -$60.9 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Enterprise Value data on file, last reported at -$8.1 million in Q4 2025.
- Quarterly Enterprise Value rose 86.77% year-over-year to -$8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.1 million (up 86.77% YoY) and the FY2025 annual result came in at -$8.1 million, up 86.77% from the prior year.
- Enterprise Value advanced to -$8.1 million in Q4 2025 per ANL's latest filing, from -$60.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$8.1 million in Q4 2025 and bottomed at -$98.5 million in Q4 2023.
- The 4-year median for Enterprise Value is -$62.5 million (2022), against an average of -$65.1 million.
- The widest annual swing landed in 2023, when Enterprise Value tumbled 53.79%; it then soared 86.77% in 2025.
- Tracing ANL's Enterprise Value over 4 years: stood at -$64.0 million in 2022, then plunged by 53.79% to -$98.5 million in 2023, then surged by 38.16% to -$60.9 million in 2024, then soared by 86.77% to -$8.1 million in 2025.
- Per Business Quant, the three latest ANL Enterprise Value figures stand at -$8.1 million (Q4 2025), -$60.9 million (Q2 2025), and -$60.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | -8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.06 Mn |
| Jun 30, 2025 | -60.91 Mn |
| Dec 31, 2024 | -60.91 Mn |
| Jun 30, 2024 | -97.99 Mn |
| Dec 31, 2023 | -98.49 Mn |
| Dec 31, 2022 | -64.05 Mn |